Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 6, 2021; 9(19): 5073-5081
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5073
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5073
Clinical application of individualized total arterial coronary artery bypass grafting in coronary artery surgery
Wei-Guang Chen, Bai-Chun Wang, Yong-Ri Jiang, Ye-Yang Wang, Yang Lou, Second Ward, Department of Heart and Great Arteries Surgery, Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China
Author contributions: Chen WG, Wang BC, Jiang YR, Wang YY, and Lou Y constructed the study, collected and recorded data, and wrote the manuscript; Wang BC critically read the manuscript and proposed comments; All authors approved the final version of the manuscript.
Institutional review board statement: The study was reviewed and approved by the Fourth Affiliated Hospital of Harbin Medical University Institutional Review Board.
Informed consent statement: All study participants provided informed written consent.
Conflict-of-interest statement: There is no conflict of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bai-Chun Wang, MD, Chief Physician, Second Ward, Department of Heart and Great Arteries Surgery, Fourth Affiliated Hospital of Harbin Medical University, No. 37 Palace Street, Nangang District, Harbin 150001, Heilongjiang Province, China. baichun705@163.com
Received: February 25, 2021
Peer-review started: February 25, 2021
First decision: April 4, 2021
Revised: April 19, 2021
Accepted: April 26, 2021
Article in press: April 26, 2021
Published online: July 6, 2021
Processing time: 118 Days and 22.1 Hours
Peer-review started: February 25, 2021
First decision: April 4, 2021
Revised: April 19, 2021
Accepted: April 26, 2021
Article in press: April 26, 2021
Published online: July 6, 2021
Processing time: 118 Days and 22.1 Hours
Core Tip
Core Tip: To determine whether total arterial revascularization is superior to conventional coronary artery bypass surgery (CABG), we observed the efficacy and clinical outcomes in patients receiving three major arterial grafts during arterial revascularization surgery. All patients were discharged without occurrence of death. Over a follow-up of 3 mo to 1 year, the number of anastomoses was high, the graft occlusion rate was low, and no severe complications occurred. The use of arterial conduits generally provides significantly better late survival especially in patients with multi-vessel coronary disease, cardiac event-free survival and improved health-related quality of life compared to conventional CABG.